cf9a541aa8b83c3b81dca0772ab75c5b.jpg

Qase3D and Waveland introduce MDR Management System

Qase3D, a company focused on regulatory compliance and quality systems for medical 3D printing operations, has partnered with Waveland European Lawyers to introduce an MDR Management System for hospital-based Point-of-Care (PoC) 3D printing labs. The system addresses compliance with the European Medical Device Regulation (MDR) for facilities producing custom-made medical devices, including anatomical models, surgical guides, and patient-specific implants used in clinical settings.

dcc89f1679befc09a8411ec488dd8b40.jpg

ARPA-H Launches THEA Program to Advance Whole Eye Transplantation

The Advanced Research Projects Agency for Health (ARPA-H), part of the U.S. Department of Health and Human Services, has announced award recipients under its Transplantation of Human Eye Allografts (THEA) program. With funding of up to $125 million, the initiative aims to develop the first complete human eye transplantation procedure, targeting restoration of vision for people who are blind or visually impaired.

b9705e57c12f427209f4d9de011eacba.jpg

RadioMatrix: Stratasys Expands Access to Patient-Specific Radiopaque 3D Printing for Medical Imaging

3D printer OEM Stratasys has announced that its RadioMatrix radiopaque 3D printing material is now fully commercially available in the United States. Previously deployed in limited settings, the material can now be widely used by healthcare providers, medical device manufacturers, and research institutions for advanced medical imaging, education, and training purposes.

4bc276b544a2fb9d49486c2ca4513ef0.jpg

SCG completes 3D printed pedestrian bridge in Bangkok’s Ong Ang Canal district Construction 3D Printing

SCG has completed a 3D printed pedestrian bridge spanning Bangkok’s historic Ong Ang Canal, marking one of Thailand’s first uses of large-scale digital fabrication for public infrastructure. The project, finished in 2025 under the Bangkok Metropolitan Administration’s canal revitalization program, combines architectural innovation with local cultural references and sustainability-focused materials research.

Why Big Pharma Hasn’t Fully Adopted 3D Printing—Yet: Inside Triastek’s Push to Modernize Drug Manufacturing

In pharmaceutical manufacturing, tablets have long been produced through standardized processes that leave little room for fine-tuning how a drug behaves once ingested. Chinese pharmaceutical technology company Triastek is challenging that model. By applying 3D printing to drug product development and manufacturing, the company is introducing a more controlled and predictable way to engineer oral medications.